tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Foghorn Therapeutics Advances FHD-909 Phase 1 Trial
PremiumCompany AnnouncementsFoghorn Therapeutics Advances FHD-909 Phase 1 Trial
2M ago
Foghorn Therapeutics reports Q1 EPS (30c), consensus (29c)
Premium
The Fly
Foghorn Therapeutics reports Q1 EPS (30c), consensus (29c)
2M ago
Foghorn Therapeutics sees cash runway into 2027
Premium
The Fly
Foghorn Therapeutics sees cash runway into 2027
2M ago
Foghorn Therapeutics announces new preclinical data at AACR
PremiumThe FlyFoghorn Therapeutics announces new preclinical data at AACR
3M ago
Foghorn Therapeutics Presents Preclinical Data at AACR 2025
Premium
Company Announcements
Foghorn Therapeutics Presents Preclinical Data at AACR 2025
3M ago
Foghorn Therapeutics initiated with an Outperform at Citizens JMP
Premium
The Fly
Foghorn Therapeutics initiated with an Outperform at Citizens JMP
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
Premium
Stock Analysis & Ideas
Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
5M ago
Foghorn Therapeutics Advances Drug Development in Oncology
Premium
Company Announcements
Foghorn Therapeutics Advances Drug Development in Oncology
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100